Brandy Fidler

Marc Appel, founder of Pacific Bridge, an investment firm specializing in Asian biotech, spoke with BioXconomy about China’s rise in the biotech sector and how this transformation is reshaping drug development, accelerating patient access to new therapies, and creating both opportunities and competitive pressures for the global pharmaceutical industry.

When Celia Eckert thinks about what makes a compliance culture really work, she doesn’t start with policies or procedures. She starts with a feeling. “I’ve learned that people will forget what you said, people will forget what you did, but people will never forget how you made them feel,” she said, quoting Maya Angelou.

Major pharmacy chains and manufacturers align services around the federal program’s flat monthly price point for weight management drugs.